SCHEMBL2986605

SCHEMBL2986605

O=C(c1ccc(O)cc1)C(O)CO

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.48
BLM P54132 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
ABL1 P00519 1/20 0.47
POLB P06746 1/20 0.47
ALPI P09923 1/20 0.47
GAA P10253 1/20 0.47
ALPG P10696 1/20 0.47
APEX1 P27695 1/20 0.47
CASP3 P42574 1/20 0.47
RECQL P46063 1/20 0.47
CASP7 P55210 1/20 0.47
CASP6 P55212 1/20 0.47
MCL1 Q07820 1/20 0.47
RIN1 Q13671 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
LMNA P02545 2/20 0.46
ESR1 P03372 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7002681 0.81 PDPK1 (0.52) PDPK1BLMKDM4EALDH1A1ABL1
SCHEMBL28376164 0.81 LMNA (0.56) PDPK1ALDH1A1TDP1LMNAESR1
SCHEMBL2985359 0.80 CES1 (0.54) BLMKDM4EALDH1A1POLBRECQL
SCHEMBL11990926 0.78 SLC6A2 (0.55) PDPK1ALDH1A1TDP1LMNAESR1
SCHEMBL27937876 0.78 LMNA (0.45) PDPK1BLMKDM4EALDH1A1ABL1
SCHEMBL670290 0.78 KDM4E (0.58) KDM4EPOLBGAAALPGRECQL
Terephthalic Acid SCHEMBL27941219 0.78 TSHR (0.54) TDP1L3MBTL1LMNAPKMCES2
SCHEMBL8982949 0.77 PDPK1 (0.57) PDPK1BLMKDM4EALDH1A1ABL1
SCHEMBL18101799 0.77 LMNA (0.51) PDPK1BLMKDM4EALDH1A1ABL1
SCHEMBL29085758 0.77 LMNA (0.51) PDPK1BLMKDM4EALDH1A1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255228-A1 Ascorbic Acid Complexes for Skin Care Including Treatment of Dark Skin & Wrinkles BIODERM RESEARCH (US) 2008-10-16 US claimed
US-20080254130-A1 Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction BIODERM RESEARCH (US) 2008-10-16 US claimed
US-7427690-B2 Multifunction “crown complexes” from amino acids and peptides for skin and hair restoration BIODERM RESEARCH (US) 2008-09-23 US claimed
US-20070099886-A1 Multifunction \"Crown Complexes\" from Amino Acids and Peptides for Skin and Hair Restoration BIODERM RESEARCH (US) 2007-05-03 US claimed
US-20060074108-A1 Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition BIODERM RESEARCH (US) 2006-04-06 US claimed
US-20050271608-A1 Skin whitening compositions based on hydroxyaryl alkyl ketones and their isosteric derivatives GUPTA SHYAM K 2005-12-08 US claimed
EP-1006405-B1 Black and white thermographic recording material with improved image tone AGFA GEVAERT (BE) 2003-07-23 EP claimed
EP-0978760-B1 Thermographic recording materials AGFA GEVAERT (BE) 2003-07-02 EP claimed
US-6313065-B1 CONTAINING LIGHT-INSENSITIVE ORGANIC SILVER SALT, 1,2-DIHYDROXYBENZENE DERIVATIVE, POLYMER WITH ACTIVE HYDROGEN ATOMS WHICH HAVE, AT LEAST PARTIALLY, REACTED WITH A POLYISOCYANATE AGFA-GEVAERT (BE) 2001-11-06 US claimed
US-6211115-B1 Reducing agents for use in thermographic recording materials AGFA-GEVAERT (BE) 2001-04-03 US claimed
EP-1006405-A1 Black and white thermographic recording material with improved image tone AGFA-GEVAERT N.V. (BE) 2000-06-07 EP claimed
EP-0978760-A1 Novel reducing agents for use in thermographic recording materials AGFA-GEVAERT N.V. (BE) 2000-02-09 EP claimed
US-8227426-B2 Chiral complexes of ascorbic acid with natural antioxidant and anti-inflammatory ketones including aloe, citrus, ginger, and mango for skin and hair care ISLAND KINETICS INC. (US) 2012-07-24 US disclosed
US-20110059907-A1 Chiral Complexes of Ascorbic Acid with Natural Antioxidant and Anti-Inflammatory Ketones Including Aloe, Citrus, Ginger, and Mango for Skin and Hair Care ISLAND KINETICS INC. (US) 2011-03-10 US disclosed
US-7834210-B2 Hair loss prevention by natural amino acid and peptide complexes BIODERM RESEARCH (US) 2010-11-16 US disclosed
US-7777073-B2 Topical delivery system for antiaging and skin whitening agents BIODERM RESEARCH (US) 2010-08-17 US disclosed
US-6313065-B1 CONTAINING LIGHT-INSENSITIVE ORGANIC SILVER SALT, 1,2-DIHYDROXYBENZENE DERIVATIVE, POLYMER WITH ACTIVE HYDROGEN ATOMS WHICH HAVE, AT LEAST PARTIALLY, REACTED WITH A POLYISOCYANATE AGFA-GEVAERT (BE) 2001-11-06 US disclosed
US-6211115-B1 Reducing agents for use in thermographic recording materials AGFA-GEVAERT (BE) 2001-04-03 US disclosed
EP-1006405-A1 Black and white thermographic recording material with improved image tone AGFA-GEVAERT N.V. (BE) 2000-06-07 EP disclosed
EP-0978760-A1 Novel reducing agents for use in thermographic recording materials AGFA-GEVAERT N.V. (BE) 2000-02-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110059907-A1 Chiral Complexes of Ascorbic Acid with Natural Antioxidant and Anti-Inflammatory Ketones Including Aloe, Citrus, Ginger, and Mango for Skin and Hair Care GLA, LPO, PLOD3 PDPK1 2318/4885BLM 3648/4885KDM4E 1594/4885
US-20080254130-A1 Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction PSMB1, PLOD3, CUTA PDPK1 2086/4885BLM 2586/4885KDM4E 513/4885
US-20080255228-A1 Ascorbic Acid Complexes for Skin Care Including Treatment of Dark Skin & Wrinkles PROC, COL1A1, CUTA PDPK1 1471/4885BLM 3438/4885KDM4E 1689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.